Squarepoint Ops LLC Eloxx Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.53 - $3.4 $34,592 - $46,488	-13,673 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.56 - $3.65 $58,386 - $136,608	-37,427 Reduced 73.24%	13,673 $41,000
Q1 2020 May 15, 2020	SELL	$1.96 - $7.96 $24,766 - $100,582	-12,636 Reduced 19.83%	51,100 $100,000
Q4 2019 Feb 14, 2020	BUY	$3.19 - $7.56 $167,691 - $397,414	52,568 Added 470.7%	63,736 $469,000
Q3 2019 Nov 14, 2019	BUY	$4.37 - $9.91 $48,804 - $110,674	11,168 New	11,168 $50,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.